Articles of Association for Genmab A/S
February 15, 2017 16:06 ET
|
Genmab A/S
Genmab A/S has published its Articles of Association dated February 10, 2017. The Articles of Association can be found on Genmab’s website: http://ir.genmab.com/releases.cfm
Contact:
Rachel...
Grant of Restricted Stock Units and Warrants to Employees in Genmab
February 10, 2017 12:55 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; February 10, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 630 restricted stock units and...
Tildeling af restricted stock units og warrants til medarbejdere i Genmab
February 10, 2017 12:55 ET
|
Genmab A/S
Selskabsmeddelelse
København, Danmark, 10. februar 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) offentliggjorde i dag, at på et bestyrelsesmøde har bestyrelsen besluttet at tildele 630 restricted...
Genmab ansætter Judith Klimovsky, MD, som Chief Development Officer
February 08, 2017 01:38 ET
|
Genmab A/S
Selskabsmeddelelse
Judith Klimovsky, MD, ansættes som Executive Vice President og Chief Development Officer (CDO)
Den nye CDO indtræder i Genmabs nuværende direktion, som i øjeblikket...
Genmab Appoints Judith Klimovsky, MD, as Chief Development Officer
February 08, 2017 01:38 ET
|
Genmab A/S
Company Announcement
Judith Klimovsky, MD, appointed as Executive Vice President and Chief Development Officer (CDO)
CDO joins Genmab’s current Executive team of CEO and CFO
Dr....
Genmab Announces Updated 2016 Financial Guidance
February 06, 2017 00:39 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; February 6, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that it has updated its 2016 Financial Guidance. Based on preliminary reporting,...
Genmab opdaterer resultatforventningerne til 2016
February 06, 2017 00:39 ET
|
Genmab A/S
Selskabsmeddelelse
København, Danmark; 6. februar 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) har i dag opdateret sine resultatforventninger til 2016. På baggrund af de foreløbige tal opjusterer...
Genmab offentliggør nettoomsætningen for DARZALEX® (daratumumab) i 2016
January 24, 2017 06:52 ET
|
Genmab A/S
Selskabsmeddelelse
Nettoomsætningen for DARZALEX i 2016 udgjorde i alt USD 572 mio.
Genmab vil modtage royalties fra Janssen Biotech, Inc. af det globale salg
København, Danmark; 24....
Genmab Announces 2016 Net Sales Figures for DARZALEX® (Daratumumab)
January 24, 2017 06:52 ET
|
Genmab A/S
Company Announcement
Net sales of DARZALEX in 2016 totaled USD 572 million
Genmab will receive royalties on worldwide sales from Janssen Biotech, Inc.
Copenhagen, Denmark; January 24,...
Genmab Achieves USD 25 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
January 06, 2017 15:12 ET
|
Genmab A/S
Company Announcement
First sales volume milestone reached in DARZALEX (daratumumab) collaboration with Janssen
Genmab to receive milestone payment of USD 25 million
Copenhagen, Denmark;...